Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
Abstract Background Genomic initiatives such as The Cancer Genome Atlas (TCGA) contain data from -omics profiling of thousands of tumor samples, which may be used to decipher cancer signaling, and related alterations. Managing and analyzing data from large-scale projects, such as TCGA, is a demandin...
Main Authors: | Marta Lucchetta, Isabelle da Piedade, Mohamed Mounir, Marina Vabistsevits, Thilde Terkelsen, Elena Papaleo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5965-x |
Similar Items
-
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
by: Talip Zengin, et al.
Published: (2020-09-01) -
In silico assessment of EpCAM transcriptional expression and determination of the prognostic biomarker for human lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC)
by: Abu Tayab Moin, et al.
Published: (2021-09-01) -
Loss of Long Distance Co-Expression in Lung Cancer
by: Sergio Daniel Andonegui-Elguera, et al.
Published: (2021-03-01) -
Identification of an eight-gene prognostic signature for lung adenocarcinoma
by: Li S, et al.
Published: (2018-09-01) -
Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma
by: Hao Zhang, et al.
Published: (2020-02-01)